PubRank

D S Reintgen

Author PubWeight™ 134.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001 10.20
2 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001 9.68
3 Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996 4.13
4 Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999 3.74
5 Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998 2.90
6 Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol 1999 2.36
7 Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998 2.11
8 Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. Plast Reconstr Surg 1999 2.02
9 In support of sentinel node biopsy as a standard of care for patients with malignant melanoma. Dermatol Surg 2000 1.95
10 Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol 1999 1.68
11 Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer J Sci Am 1998 1.67
12 Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol 2001 1.66
13 Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol 1998 1.64
14 Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 1998 1.62
15 Detection of submicroscopic lymph node metastases in patients with melanoma. Arch Surg 1991 1.61
16 Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery 1984 1.59
17 Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med 1998 1.54
18 Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998 1.54
19 The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg 2001 1.53
20 Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol 1999 1.50
21 Malignant melanoma and pregnancy. Cancer 1985 1.47
22 Influence of physician communication on newly diagnosed breast patients' psychologic adjustment and decision-making. Cancer 1994 1.46
23 Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol 1994 1.43
24 Analysis of residual cancer after diagnostic breast biopsy: an argument for fine-needle aspiration cytology. Ann Surg Oncol 1995 1.42
25 Monoamine oxidase and catechol-O-methyltransferase activity in hamster and rat insulinomas. Diabetologia 1979 1.41
26 Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996 1.41
27 Lymphatic mapping and sentinel node biopsy in the management of high-risk melanoma. J Am Acad Dermatol 1998 1.38
28 Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000 1.38
29 Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 1995 1.35
30 Lethal "thin" malignant melanoma. Identifying patients at risk. Ann Surg 1988 1.30
31 Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg 2001 1.28
32 Touch preparation cytology of breast lumpectomy margins with histologic correlation. Arch Surg 1991 1.27
33 Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg 1983 1.26
34 Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery 2001 1.26
35 Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 2001 1.15
36 The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg 1999 1.14
37 Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997 1.12
38 Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 2001 1.10
39 Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996 1.09
40 Metastatic malignant melanoma with an unknown primary. Surg Gynecol Obstet 1983 1.06
41 Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma. Surg Oncol Clin N Am 1999 1.06
42 Lymphoscintigraphy in malignant melanoma. Ann Plast Surg 1992 1.04
43 Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Cancer Res 1995 1.04
44 Malignant melanoma arising during pregnancy. A study of 100 patients. Ann Surg 1990 1.03
45 Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol 1997 1.01
46 Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Dermatol 1996 1.01
47 Malignant melanoma in black American and white American populations. A comparative review. JAMA 1982 0.99
48 Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol 1996 0.99
49 Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma. Ann Surg Oncol 1998 0.98
50 Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med 2000 0.97
51 Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control 2000 0.95
52 Radiologic, endoscopic and surgical considerations of malignant melanoma metastatic to the small intestine. Curr Surg 1984 0.94
53 Learning curves and certification for breast cancer lymphatic mapping. Surg Oncol Clin N Am 1999 0.93
54 Sex related survival differences in instances of melanoma. Surg Gynecol Obstet 1984 0.92
55 Sentinel node excision for the diagnosis of metastatic neuroendocrine carcinoma of the skin: a case report. Ann Plast Surg 1997 0.92
56 Lymphatic mapping in the treatment of breast cancer. Oncology (Williston Park) 1998 0.90
57 Multiple primary melanomas: implications for screening and follow-up programs for melanoma. Ann Surg Oncol 1997 0.90
58 Lymphoscintigraphy for malignant melanoma. Surgical considerations. Am Surg 1983 0.89
59 Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma. Ann Surg 2000 0.89
60 Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. J Am Acad Dermatol 2001 0.88
61 Imprint cytology of needle-localized breast lesions. Acta Cytol 1993 0.88
62 Utility of internal mammary lymph node removal when noted by intraoperative gamma probe detection. Ann Surg Oncol 2001 0.87
63 The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol 1999 0.86
64 Fine needle aspiration biopsy of palpable breast lesions. Review and statistical analysis of 1875 cases. Surg Oncol 1993 0.86
65 Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol 1998 0.86
66 Cytology of lumpectomy specimens. Acta Cytol 1991 0.85
67 The concept of lymph node dissections in patients with malignant melanoma. Ann Plast Surg 1992 0.85
68 Clinical relevance of internal mammary node mapping as a guide to radiation therapy. Am J Surg 2001 0.85
69 Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg 1999 0.85
70 Treatment of stage IV malignant melanoma with dacarbazine, carmustine, cisplatin, and tamoxifen regimens: a University of South Florida and H. Lee Moffitt Melanoma Center Study. Ann Plast Surg 1992 0.84
71 The role of lymphoscintigraphy in the management of the patient with breast cancer. Ann Surg Oncol 2001 0.84
72 Role of fine needle aspiration cytology after lumpectomy. Acta Cytol 1995 0.83
73 Importance of missed axillary micrometastases in breast cancer patients. Breast J 2002 0.83
74 The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg 1994 0.83
75 Sentinel lymphadenectomy: a safe answer to less axillary surgery? Recent Results Cancer Res 1998 0.83
76 The process of clinical trials: a model for successful clinical trial participation. Oncol Nurs Forum 2001 0.81
77 Local recurrence of breast cancer after cytological evaluation of lumpectomy margins. Am Surg 1998 0.81
78 The current management and prognosis of acral lentiginous melanoma. Ann Plast Surg 1992 0.81
79 Cytochemistry of sex steroid receptors: a critique. Breast Cancer Res Treat 1981 0.81
80 Immunodiagnosis of tumors in vivo using radiolabeled monoclonal antibody A2B5. J Surg Oncol 1983 0.81
81 Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg 1997 0.81
82 Detection of occult lymph node metastases in malignant melanoma. Ann Plast Surg 1992 0.79
83 Breast cancer patients' personality style, age, and treatment decision making. J Surg Oncol 1996 0.79
84 Lymphatic mapping in breast cancer. Hematol Oncol Clin North Am 1999 0.78
85 Breast cancer screening in childhood cancer survivors. Med Pediatr Oncol 2000 0.78
86 Techniques for lymphatic mapping in breast carcinoma. Surg Oncol Clin N Am 1999 0.78
87 Lymphoscintigraphy as a predictor of lymphatic drainage from cutaneous melanoma. Ann Surg Oncol 1997 0.78
88 Etiology and prognosis of local recurrence in malignant melanoma of the skin. Ann Plast Surg 1992 0.78
89 Role of lymphatic mapping and sentinel node biopsy in the detection of melanoma nodal metastases. Eur J Cancer 1998 0.77
90 Cutaneous melanoma of the head and neck: advances in evaluation and treatment. Plast Reconstr Surg 2000 0.77
91 The use of selective lymphadenectomy in squamous cell carcinoma of the wrist: a case report. J Hand Surg Am 1997 0.77
92 Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma. Ann Surg Oncol 1998 0.77
93 Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol 1997 0.76
94 Adjuvant chemotherapy in malignant melanoma using dacarbazine, carmustine, cisplatin, and tamoxifen: a University of South Florida and H. Lee Moffitt Melanoma Center Study. Ann Plast Surg 1992 0.76
95 Malignant melanoma in the American black. Curr Surg 1983 0.76
96 Metastatic melanoma with an unknown primary. Ann Plast Surg 1992 0.76
97 Controversial topics in breast lymphatic mapping. Semin Oncol 2004 0.76
98 The clinical relevance of sentinel lymph nodes identified with radiolymphoscintigraphy. J Fla Med Assoc 1997 0.76
99 Changing standards of surgical care for the melanoma patient. Ann Surg Oncol 1996 0.75
100 Molecular staging of melanoma. Ann Surg Oncol 1999 0.75
101 A melanoma vaccine that works? Evidence for a phase III national trial. Ann Surg Oncol 1999 0.75
102 Functional and morphologic changes associated with insulinoma transplantation into diabetic rats. Am J Pathol 1983 0.75
103 Regional nodal surgery for melanoma impacts recurrence rates and survival. Ann Surg Oncol 2000 0.75
104 Radioguidance for nonpalpable primary lesions and sentinel lymph node(s). Am J Surg 2001 0.75
105 Emerging evidence for a survival benefit associated with regional lymph node dissection for melanoma. Ann Surg Oncol 2000 0.75
106 Treatment of the primary in malignant melanoma of the skin. Ann Plast Surg 1992 0.75
107 Molecular staging for melanoma and breast cancer. Surg Oncol Clin N Am 1999 0.75
108 The human genome project: a dream becoming a reality. Surgery 1999 0.75
109 Sentinel lymph node biopsy for breast cancer: combined dye-isotope technique. Breast Cancer 2000 0.75
110 Psychosocial aspects of melanoma. Ann Plast Surg 1992 0.75
111 A molecular technique useful in the detection of occult metastases in patients with melanoma : rt-PCR analysis of sentinel lymph nodes and peripheral blood. Methods Mol Med 2001 0.75
112 Juvenile malignant melanoma of the head and neck. Laryngoscope 1988 0.75
113 Radioguided surgery for melanoma. Surg Oncol Clin N Am 1999 0.75
114 Historical perspectives and future applications. Surg Oncol Clin N Am 1999 0.75
115 Prognosis in malignant melanoma. Hematol Oncol Clin North Am 1998 0.75
116 Lymphatic mapping for melanomas of the upper extremity. J Hand Surg Am 1999 0.75
117 The clinical relevance of molecular staging for melanoma. Recent Results Cancer Res 2001 0.75